secwatch.observer — SEC 8-K summary
======================================

Issuer:     Akebia Therapeutics, Inc. (AKBA)
CIK:        0001517022
Form:       8-K
Filed at:   2025-02-07T23:59:59+00:00
Accession:  0001517022-25-000010
Event type: debt
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 2.03, 3.02
LLM model:  deepseek-v4-flash:cloud@v2

Akebia draws $9.3M net from extended loan tranche; issues warrant for 1.15M shares
--------------------------------------------------------------------------------

- Extended Tranche C expiry from Dec 31, 2024 to Feb 3, 2025; interest accrues from Dec 31, 2024.
- Drew $10M Tranche C on Feb 3, 2025; net proceeds of $9.3M after debt issuance costs and interest.
- Issued warrant to Kreos Capital affiliate for 1,153,846 shares at $1.30 exercise, 8-year term.
- Warrant not registered; relies on Section 4(a)(2) and Rule 506(b) exemption.
- Loan facility total $55M; prior tranches of $37M and $8M already drawn.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1517022/000151702225000010/0001517022-25-000010-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1517022/000151702225000010/akba-20250203.htm
  HTML page:      https://secwatch.observer/filing/0001517022-25-000010

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer